Innoviva (NASDAQ:INVA) reported quarterly earnings of $2.22 per share which beat the analyst consensus estimate of $0.36 by 516.67 percent. This is a 400 percent increase over losses of $(0.74) per share from the same period last year. The company reported quarterly sales of $97.994 million which missed the analyst consensus estimate of $101.555 million by 3.51 percent. This is a 10.56 percent increase over sales of $88.632 million the same period last year.